Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 2Phase 3 Interventional

Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis

ClinicalTrials.gov ID: NCT01273779

Public ClinicalTrials.gov record NCT01273779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 8:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OASIS: A Phase 2/3 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis

Study identification

NCT ID
NCT01273779
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Agennix
Industry
Enrollment
1,280 participants

Conditions and interventions

Conditions

Interventions

  • Talactoferrin alfa Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2011
Primary completion
Dec 31, 2013
Completion
Nov 30, 2014
Last update posted
Feb 2, 2012

2011 – 2014

United States locations

U.S. sites
34
U.S. states
26
U.S. cities
34
Facility City State ZIP Site status
University of Alabama - Birmingham Birmingham Alabama 35249
Providence Hospital Mobile Alabama 36608
Maricopa Medical Center Maricopa Arizona 85008
St. Joseph Hospital Orange California 92868
Sharp Memorial Hospital San Diego California 92123
Stanford University Hospital Stanford California 94305-5117
UCLA Medical Center Sylmar California 91342
Denver Health Medical Center Denver Colorado 80204
Christiana Care Health Services Newark Delaware 19718
George Washington University Hospital Washington D.C. District of Columbia 20037
Bay Area Chest Physicians Clearwater Florida 33756
Eastern Idaho Medical Consultants Idaho Falls Idaho 83404
West Suburban Hospital Medical Center Oak Park Illinois 60302
Peoria Pulmonary Associates Peoria Illinois 61603
Methodist Research Institute Indianapolis Indiana 46202
University of Iowa Iowa City Iowa 52242
University of Kansas Medical Center Kansas City Kansas 66160
Baystate Medical Center Springfield Massachusetts 01199
Henry Ford Hospital Detroit Michigan 48202
St. Johns Mercy Medical Center St Louis Missouri 63141
University of Nebraska Medical Center Omaha Nebraska 68198
Cooper University Hospital Camden New Jersey 08103
Moses Cone Memorial Hospital Greensboro North Carolina 27401
Wake Forest University Health Sciences Winston-Salem North Carolina 27517
Riverside Methodist Hospital Columbus Ohio 43214
St. Vincent Mercy Medical Center Toledo Ohio 43608
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104
Cancer Institute, Hillman Cancer Center Pittsburgh Pennsylvania 15232
Rhode Island Hospital Providence Rhode Island 02903
University of Tennessee Memphis Tennessee 38163
Texas Tech Health Science Center El Paso Texas 79905
Baylor College of Medicine Houston Texas 77030
LDS Hospital Murray Utah 84157
University of Wisconsin Medical School Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01273779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2012 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01273779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →